Aliyaskarova, Umit
Baiken, Yeldar
Renaud, Flore
Couve, Sophie
Kisselev, Alexei F.
Saparbaev, Murat
Groisman, Regina
Funding for this research was provided by:
Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (AP09260233)
Nazarbayev University CRP (091019CRP2111)
Ligue Contre le Cancer Comité du Val de Marne
Fondation ARC
National Institute of Health (5R01CA213223)
La Ligue Nationale Française Contre le Cancer (Equipe LNCC 2016)
Electricité de France (RB 2021-05)
Agence Nationale de la Recherche (ANR-22-CE12-0034-01)
Article History
Received: 11 July 2022
Accepted: 23 March 2023
First Online: 30 March 2023
Competing interests
: AFK is the founder and chief scientific officer of InhiProt LLC. The other authors declare no competing interests.